These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 25550209

  • 1. Ezetimibe: rescued by randomization (clinical and mendelian).
    McPherson R, Hegele RA.
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):e13-5. PubMed ID: 25550209
    [No Abstract] [Full Text] [Related]

  • 2. Ezetimibe + statin: insufficient benefit.
    Prescrire Int; 2016 Oct; 25(175):245-246. PubMed ID: 30645833
    [Abstract] [Full Text] [Related]

  • 3. Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.
    Storey BC, Staplin N, Haynes R, Reith C, Emberson J, Herrington WG, Wheeler DC, Walker R, Fellström B, Wanner C, Landray MJ, Baigent C, SHARP Collaborative Group.
    Kidney Int; 2018 Apr; 93(4):1000-1007. PubMed ID: 29146277
    [Abstract] [Full Text] [Related]

  • 4. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
    Masana L, Pedro-Botet J, Civeira F.
    Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
    [No Abstract] [Full Text] [Related]

  • 5. Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors and Cardiovascular Risk: Does a Further Analysis of the Fourier Trial Suggest Changes in the Target of Lipid Lowering Therapy?
    Cervelli N, Tocci G, Ferri C.
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):5-7. PubMed ID: 29305812
    [No Abstract] [Full Text] [Related]

  • 6. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM, Farmer JA.
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [Abstract] [Full Text] [Related]

  • 7. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF.
    Angiology; 2006 Dec; 59(6):661-3. PubMed ID: 18796445
    [No Abstract] [Full Text] [Related]

  • 8. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.
    Khan SU, Talluri S, Riaz H, Rahman H, Nasir F, Bin Riaz I, Sattur S, Ahmed H, Kaluski E, Krasuski R.
    Eur J Prev Cardiol; 2018 May; 25(8):844-853. PubMed ID: 29569492
    [Abstract] [Full Text] [Related]

  • 9. Editorial: collecting new external evidence for cholesterol management.
    Streja D.
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):121-3. PubMed ID: 26863279
    [No Abstract] [Full Text] [Related]

  • 10. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
    Ahmed MH, Khalil AA.
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
    [Abstract] [Full Text] [Related]

  • 11. Nonstatin Therapy for Dyslipidemia.
    Ahmed HM, Nissen SE.
    Circ Res; 2018 Oct 12; 123(9):1036-1038. PubMed ID: 30355163
    [No Abstract] [Full Text] [Related]

  • 12. Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients.
    Ahmed O, Littmann K, Gustafsson U, Pramfalk C, Öörni K, Larsson L, Minniti ME, Sahlin S, Camejo G, Parini P, Eriksson M.
    J Am Heart Assoc; 2018 Dec 18; 7(24):e009876. PubMed ID: 30561264
    [Abstract] [Full Text] [Related]

  • 13. An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome.
    Drexel H, Coats AJS, Spoletini I, Bilato C, Mollace V, Perrone Filardi P, Rosano GMC.
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr 01; 6(2):115-121. PubMed ID: 31873726
    [Abstract] [Full Text] [Related]

  • 14. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
    Lancellotti P, Pierard LA, Scheen AJ.
    Rev Med Liege; 2015 Sep 01; 70(9):450-5. PubMed ID: 26638446
    [Abstract] [Full Text] [Related]

  • 15. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalán R, Špinar J, Park JG, White JA, Bohula EA, Braunwald E, IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators.
    Circulation; 2018 Apr 10; 137(15):1571-1582. PubMed ID: 29263150
    [Abstract] [Full Text] [Related]

  • 16. Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients.
    Ghanim H, Green K, Abuaysheh S, Patel R, Batra M, Chaudhuri A, Makdissi A, Kuhadiya ND, Dandona P.
    Atherosclerosis; 2017 Aug 10; 263():278-286. PubMed ID: 28711708
    [Abstract] [Full Text] [Related]

  • 17. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Breuer HW.
    Dtsch Med Wochenschr; 2010 Nov 10; 135(44):2201; author reply 2202. PubMed ID: 20979008
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients.
    Cerda A, Rodrigues AC, Alves C, Genvigir FD, Fajardo CM, Dorea EL, Gusukuma MC, Pinto GA, Hirata MH, Hirata RD.
    Cardiovasc Ther; 2015 Aug 10; 33(4):168-76. PubMed ID: 25903419
    [Abstract] [Full Text] [Related]

  • 19. Drugs for lipids.
    Treat Guidel Med Lett; 2011 Mar 10; 9(103):13-20. PubMed ID: 21350395
    [No Abstract] [Full Text] [Related]

  • 20. Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients.
    Descamps O, Tomassini JE, Lin J, Polis AB, Shah A, Brudi P, Hanson ME, Tershakovec AM.
    Atherosclerosis; 2015 Jun 10; 240(2):482-9. PubMed ID: 25913444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.